Recording: New to MOUD Provider Training

Cost: Free! 

Questions? Email Lauren at [email protected] 

How: 

Click Here to view

What?

There is no longer a federal requirement for providers to submit a notice of intent or obtain a waiver to prescribe medication for opioid use disorder (MOUD).

However, most providers feel more comfortable with education and training. Our training with Dr. Mendez will help providers feel more confident and ready to treat patients with opioid use disorders (OUD). 

According to the SAMSHA website, “All practitioners who have a current DEA registration that includes Schedule III authority, may now prescribe buprenorphine for Opioid Use Disorder in their practice if permitted by applicable state law and SAMHSA encourages them to do so. SAMHSA and DEA are actively working on implementation of a separate provision of the Omnibus related to training requirements for DEA registration that becomes effective in June 2023.”

SAMSHA Website: https://www.samhsa.gov/medication-assisted-treatment/removal-data-waiver-requirement

Official DEA Announcement: https://www.deadiversion.usdoj.gov/pubs/docs/A-23-0020-Dear-Registrant-Letter-Signed.pdf